Search

Your search keyword '"Ylstra, Bauke"' showing total 1,115 results

Search Constraints

Start Over You searched for: Author "Ylstra, Bauke" Remove constraint Author: "Ylstra, Bauke"
1,115 results on '"Ylstra, Bauke"'

Search Results

5. Baseline radiomics features and MYC rearrangement status predict progression in aggressive B-cell lymphoma

6. Hidden RNA profiles of cells in the tumor microenvironment accurately revealed by malignant cell fraction-informed deconvolution

7. Response to neoadjuvant chemotherapy and survival in molecular subtypes of resectable gastric cancer: a post hoc analysis of the D1/D2 and CRITICS trials

8. Genomic and microenvironmental landscape of stage I follicular lymphoma, compared with stage III/IV

9. Microsatellite instability and sex differences in resectable gastric cancer – A pooled analysis of three European cohorts

11. A multi-platform reference for somatic structural variation detection

12. Molecular pathways in post-colonoscopy versus detected colorectal cancers: results from a nested case–control study

13. Molecular characterization of colorectal cancer related peritoneal metastatic disease

14. Evolutionary trajectories of IDH-mutant astrocytoma identify molecular grading markers related to cell cycling

15. Table S1 from The Epigenetic Evolution of Glioma Is Determined by the IDH1 Mutation Status and Treatment Regimen

16. Supp Figures from The Epigenetic Evolution of Glioma Is Determined by the IDH1 Mutation Status and Treatment Regimen

17. Supplemental Figures Legends from The Epigenetic Evolution of Glioma Is Determined by the IDH1 Mutation Status and Treatment Regimen

18. Data from The Epigenetic Evolution of Glioma Is Determined by the IDH1 Mutation Status and Treatment Regimen

19. Supplementary Appendix from The Epigenetic Evolution of Glioma Is Determined by the IDH1 Mutation Status and Treatment Regimen

20. The Epigenetic Evolution of Glioma Is Determined by the IDH1 Mutation Status and Treatment Regimen

22. Tumor-Educated Platelet RNA for the Detection and (Pseudo)progression Monitoring of Glioblastoma

25. The epigenetic evolution of glioma is determined by the IDH1 mutation status and treatment regimen

26. Longitudinal characteristics of T2-FLAIR mismatch in IDH-mutant astrocytomas: relation to grade, histopathology and overall survival in the GLASS-NL cohort

27. Spatiotemporal regulation of clonogenicity in colorectal cancer xenografts

28. Chromosomal copy number heterogeneity predicts survival rates across cancers

30. Robust detection of translocations in lymphoma FFPE samples using targeted locus capture-based sequencing

31. Evolution of DNA repair defects during malignant progression of low-grade gliomas after temozolomide treatment

32. DNA copy number analysis of fresh and formalin-fixed specimens by shallow whole-genome sequencing with identification and exclusion of problematic regions in the genome assembly.

33. The Impact of Genetic Subtypes of Diffuse Large B-Cell Lymphoma for Outcome Prediction and Interpretation of FDG-PET treatment Response Monitoring

39. Combination of variations in inflammation- and endoplasmic reticulum-associated genes as putative biomarker for bevacizumab response in KRAS wild-type colorectal cancer

40. Breast tumor copy number aberration phenotypes and genomic instability

42. Copy number signatures and mutational processes in ovarian carcinoma

47. Genetic and Microenvironment Features Do Not Distinguish Follicular Lymphoma Patients Requiring Immediate or Deferred Treatment

48. Supplementary Table 1 from Mismatch Repair Status and BRAF Mutation Status in Metastatic Colorectal Cancer Patients: A Pooled Analysis of the CAIRO, CAIRO2, COIN, and FOCUS Studies

50. Supplementary Figure 2 from Chromosome 5q Loss in Colorectal Flat Adenomas

Catalog

Books, media, physical & digital resources